Evidence map›Paper›PMID 42288639›Full record

ArticleScientific reports2026

Machine learning approaches for predicting differentiated thyroid cancer recurrence using thyroglobulin levels and whole-body scans: a retrospective cohort study.

Reza Nouri, Erfan Ayubi, Shiva Borzouei, Sajjad Farashi

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Reza NouriDepartment of Internal Medicine, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
Erfan AyubiCancer Research Center, Institute of Cancer, Avicenna Health Research Institute, Hamadan University of Medical Sciences, Hamadan, Iran.
Shiva BorzoueiDepartment of Endocrinology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran. borzooeishiva@yahoo.com.
Sajjad FarashiNeurophysiology Research Center, Institute of Neuroscience and Mental Health, Avicenna Health Research Institute, Hamadan University of Medical Sciences, Hamadan, Iran. sajjad_farashi@yahoo.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although thyroid cancer generally has a good prognosis, some patients are prone to recurrence. Multiple factors influence recurrence risk. Machine learning (ML) algorithms offer potential for more accurate and precise prediction. The aim of the present study was to evaluate recurrence related factors in thyroid cancer patients using ML algorithms. This retrospective cohort study included patients with differentiated thyroid cancer who, after undergoing total thyroidectomy and ablation with radioactive iodine (RAI) were followed up over a ten-year period. Demographic data, tumor characteristics, and treatment details were extracted from medical records. Six ML algorithms were employed including logistic regression, Naïve Bayes classifier, decision tree, random forest, XGBoost and LightGBM. A total of 355 patients were included (mean age: 41.69 [Formula: see text] 14.04 years, 84.22% female). Among ML algorithms, XGBoost demonstrated superior predictive performance, achieving an accuracy of 97.66(± 2.34) % and an area under the curve of 0.99. The top predictors were the number of recurrences, first-year stimulated thyroglobulin level, regional node involvement, and first response to treatment, respectively. This study also proposed the use of whole-body scans only for high-risk patients.

Indexed as

Machine LearningNeoplasm Recurrence, LocalThyroglobulinThyroid NeoplasmsWhole Body ImagingAdultBoosting Machine Learning AlgorithmsClassification AlgorithmsFemaleHumansMaleMiddle AgedPrediction AlgorithmsPredictive Learning ModelsPrognosisRandom ForestThyroglobulinDifferentiated thyroid cancerMachine learningRecurrenceThyroglobulin

Identifiers

PMID42288639
PMCPMC13522623

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.